Terms: = Sarcomas AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2
10 results:
1. Development and validation of a pyroptosis-related prognostic signature associated with osteosarcoma metastasis and immune infiltration.
Gong Z; Wan Y; Han E; Zhou X; Huang J; Yu H; Shi Y; Lian K
Medicine (Baltimore); 2024 Apr; 103(14):e37642. PubMed ID: 38579086
[TBL] [Abstract] [Full Text] [Related]
2. Unraveling T cell exhaustion in the immune microenvironment of osteosarcoma via single-cell RNA transcriptome.
Cheng D; Zhang Z; Liu D; Mi Z; Tao W; Fu J; Fan H
Cancer Immunol Immunother; 2024 Jan; 73(2):35. PubMed ID: 38280005
[TBL] [Abstract] [Full Text] [Related]
3. Receptor tyrosine kinase gene expression profiling of orbital rhabdomyosarcoma unveils MET as a potential biomarker and therapeutic target.
Chauhan S; Sen S; Irshad K; Kashyap S; Pushker N; Meel R; Sharma MC
Hum Cell; 2024 Jan; 37(1):297-309. PubMed ID: 37914903
[TBL] [Abstract] [Full Text] [Related]
4. T2-weighted MRI radiomics in high-grade intramedullary osteosarcoma: predictive accuracy in assessing histologic response to chemotherapy, overall survival, and disease-free survival.
White LM; Atinga A; Naraghi AM; Lajkosz K; Wunder JS; Ferguson P; Tsoi K; Griffin A; Haider M
Skeletal Radiol; 2023 Mar; 52(3):553-564. PubMed ID: 35778618
[TBL] [Abstract] [Full Text] [Related]
5. In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by cd32A-chimeric receptor T cells in combination with cetuximab or panitumumab.
Caratelli S; Arriga R; Sconocchia T; Ottaviani A; Lanzilli G; Pastore D; Cenciarelli C; Venditti A; Del Principe MI; Lauro D; Landoni E; Du H; Savoldo B; Ferrone S; Dotti G; Sconocchia G
Int J Cancer; 2020 Jan; 146(1):236-247. PubMed ID: 31479522
[TBL] [Abstract] [Full Text] [Related]
6. Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric sarcomas.
Merchant MS; Bernstein D; Amoako M; Baird K; Fleisher TA; Morre M; Steinberg SM; Sabatino M; Stroncek DF; Venkatasan AM; Wood BJ; Wright M; Zhang H; Mackall CL
Clin Cancer Res; 2016 Jul; 22(13):3182-91. PubMed ID: 26823601
[TBL] [Abstract] [Full Text] [Related]
7. FCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: an international consortium study.
Geva R; Vecchione L; Kalogeras KT; Jensen BV; Lenz HJ; Yoshino T; Paez D; Montagut C; Souglakos J; Cappuzzo F; Cervantes A; Frattini M; Fountzilas G; Johansen JS; Høgdall EV; Zhang W; Yang D; Yamazaki K; Nishina T; Papamichael D; Vincenzi B; Macarulla T; Loupakis F; De Schutter J; Spindler KL; Pfeiffer P; Ciardiello F; Piessevaux H; Tejpar S
Gut; 2015 Jun; 64(6):921-8. PubMed ID: 25011934
[TBL] [Abstract] [Full Text] [Related]
8. Factors influencing survival in metastatic synovial sarcoma: importance of patterns of metastases and the first-line chemotherapy regimen.
Salah S; Yaser S; Salem A; Al Mousa A; Abu Sheikha A; Sultan I
Med Oncol; 2013; 30(3):639. PubMed ID: 23780657
[TBL] [Abstract] [Full Text] [Related]
9. Differentiation of regulatory T cells 1 is induced by CD2 costimulation.
Wakkach A; Cottrez F; Groux H
J Immunol; 2001 Sep; 167(6):3107-13. PubMed ID: 11544295
[TBL] [Abstract] [Full Text] [Related]
10. Immunophenotypic and immunoelectron microscopic characterization of major constituent cells in malignant fibrous histiocytoma using human cell lines and their transplanted tumors in immunodeficient mice.
Takeya M; Yamashiro S; Yoshimura T; Takahashi K
Lab Invest; 1995 Jun; 72(6):679-88. PubMed ID: 7783426
[TBL] [Abstract] [Full Text] [Related]
